The seroepidemiology of human T-lymphotropic viruses: Types I and II in Europe: A prospective study of pregnant women

Journal of Acquired Immune Deficiency Syndromes

Volumn 38, Issue 1, 2005, Pages 104-109

  Taylor, Graham P ^a   Bodéus, Monique ^b   Courtois, Françoise ^c   Pauli, Georg ^d   Del Mistro, Annarosa ^e   Machuca, Ana ^f   Padua, Elizabeth ^g   Andersson, Soren ^h   Goubau, Patrick ^b   Chieco Bianchi, Luigi ^e   Soriano, Vincent ^f   Coste, Joliette ^c   Ades, Anthony E ⁱ   Weber, Jonathan N ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d ROBERT KOCH INSTITUTE   (Germany)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^h SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Epidemiology; HTLV I; HTLV II; Pregnant women; Western Europe

Indexed keywords

MATERNAL ANTIBODY; VIRUS ANTIBODY;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; FRANCE; GERMANY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOASSAY; INFANT; INTRAUTERINE INFECTION; ITALY; MAJOR CLINICAL STUDY; NEWBORN SCREENING; PORTUGAL; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROEPIDEMIOLOGY; SEROPREVALENCE; SPAIN; UNITED KINGDOM;

EUROPE; FEMALE; FETAL BLOOD; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 19944426970     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200501010-00018     Document Type: Article

References (33)

1. Gessain A, Mahieux R, de The G. Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(Suppl):S132-S145.
2. Araujo A, Sheehy N, Takahashi H, et al. Concomitant infections with human immunodeficiency virus type 1 and human T-lymphotropic virus types 1 and 2. In:Brogden KA, Guthmiller J, eds. Polymicrobial Diseases. Washington, DC: ASM Press; 2002:75-97.
3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Human Immunodeficiency Viruses and Human T-cell Lymphotropic Viruses. Lyon: IARC; 1996.
4. Gessain A, Vernant JC, Maurs L, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;ii:407-409.
5. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity [letter]. Lancet. 1986;i:1031-1032.
6. Tosswill JHC, Taylor GP, Tedder RS, et al. HTLV-I-associated disease in England and Wales 1993-1997: a retrospective study of serology requests. BMJ. 1999;320:611-612.
7. Mochizuki M, Watanabe T, Yamaguchi K, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res. 1992;82:236-239.
8. Morgan O, Rodgers-Johnson P, Mora C, et al. HTLV-I and polymyositis in Jamaica. Lancet. 1989;ii:1184-1187.
9. Kitajima I, Maruyama I, Maruyama Y, et al. Polyarthritis in human T lymphocytic virus type-I associated myelopathy. Arthritis Rheum. 1989;32:1342-1344.
10. Sugimoto M, Nakashima H, Watanabe S, et al. T-lymphocytic alveolitis in HTLV-I associated myelopathy. Lancet. 1987;ii:1220.
11. Harrington WJ, Jr, Sheremata WA, Hjelle B, et al. Spastic ataxia associated with HTLV-II infection. Ann Neurol. 1993;33:411-414.
12. Murphy EL, Fridey J, Smith JW, et al. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II infected blood donors. The REDS Investigators. Neurology. 1997;48:315-320.
13. Murphy EL, Glynn SA, Fridey J, et al. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II and I infected blood donors. Retrovirus Epidemiology Donor Study. Arch Intern Med. 1999;159:1485-1491.
14. Ando Y, Nakano S, Saito K, et al. Transmission of ATL retrovirus (HTLV-I) from mother to child: comparison of bottle fed with breast fed babies. Jpn J Cancer Res. 1987;78:322-324.
15. Kaplan J, Khabbaz R, Murphy EL, et al. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:193-201.
16. Stuver SO, Tachibana N, Okayama A, et al. Heterosexual transmission of human T-cell leukaemia/lymphoma virus type I among married couples in south-western Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis. 1993;167:57-65.
17. Manns A, Wilks RJ, Murphy E, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 1992;51:886-891.
18. Toro C, Rodês B, Poveda E, et al. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation. 2003;75:102-104.
19. Krook A, Albert J, Biberfeld G, et al. Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:381-386.
20. Egan JF, O'Leary B, Lewis MJ, et al. High rate of human T-lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland. AIDS Res Hum Retroviruses. 1999;15:699-705.
21. Fukushima Y, Takahashi H, Naksono T, et al. Extraordinary high seropositivity rates of human T-cell lymphotropic virus type II (HTLV-II) in intravenous drug users in South Vietnam. AIDS Res Hum Retroviruses. 1995;11:637-644.
22. Gessain A, Gout O, Saal F, et al. Epidemiology and immunovirology of human T-cell leukaemia/lymphoma virus type-I associated adult T-cell leukaemia and chronic myelopathies as seen in France. Cancer Res. 1990;50(Suppl):5692S- 5695S.
23. Soriano V, Gutiérrez M, Vallejo A, et al. HTLV-I associated illnesses in Spain. Vox Sang. 1995;69:261-262.
24. The HTLV European Research Network. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;14:68-77.
25. Wyld PJ, Tosswill JHC, Mortimer PP, et al. Sporadic HTLV-I associated adult T-cell leukaemia (ATLL) in the UK. Br J Haematol. 1990;76:149-150.
26. Andersson S, Gessain A, Taylor GP. Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus (HTLV) types I and II. Virus Res. 2001;78:101-106.
27. Taylor GP. The HTLV European Research Network. The epidemiology and clinical impact of HTLV infection in Europe. AIDS Rev. 1999;1:195-204.
28. Ades AE, Parker S, Taylor GP, et al. HTLV in pregnant women in the UK. BMJ. 2000;320:1497-1501.
29. Machuca A, Tuset C, Soriano V, et al. Prevalence of HTLV infection in pregnant women in Spain. Sex Transm Infect. 2000;76:366-370.
30. Brennan M, Rununga J, Barbara J, et al. Prevalence of antibodies to human T-cell leukaemia/lymphoma virus in blood donors in north London. BMJ. 1993;307:1235-1239.
31. Courtois F, Barin F, Larsen M, et al. HTLV-I/II infection in pregnant women in Paris. Lancet. 1990;335:1103.
32. Machuca A, Rodés B, Soriano V. Increasing incidence of HTLV-II infection among HIV-positive Spanish inmates [abstract]. Virus Res. 2001;78:126-127.
33. Machuca A, Soriano V, and the HTLV Spanish Study Group. HTLV-II in Spain: data from the national registry up to April 2000 [abstract]. Virus Res. 2001;78:125-126.